Balkrishna Acharya, Upreti Jaya, Semwal Ankita, Kumar Ashwani, Dabas Anurag, Katiyar Prashant, Srivastava Deepika, Arya Vedpriya
Patanjali Herbal Research Department, Patanjali Research Institute, Haridwar, India.
University of Patanjali, Haridwar, India.
Health Care Women Int. 2025;46(6):702-735. doi: 10.1080/07399332.2024.2414384. Epub 2024 Oct 29.
Uterine fibroids (UF) affect 75% of women, causing pelvic discomfort, heavy bleeding, and fertility issues. Standard treatments pose risks like liver impairment and reduced bone density. Traditional medicines (TM) offer alternative approaches. We found that data from PubMed, Google Scholar, Science Direct, and bibliometric analysis using Dimension AI support TM's efficacy. In this review, we examined 21 case studies across Ayurveda, Unani, Siddha, Homeopathy, Yoga, Cupping Therapy, and Acupuncture, revealing promising outcomes in reducing fibroid size and relieving symptoms, all without significant side effects. TM interventions have tremendous potential, yet conclusive evidence is lacking. This underscores the potential of TM in managing UF and the need for further research and clinical trials for validation. Integrating TM into healthcare may enhance patient outcomes and reduce costs.
子宫肌瘤（UF）影响着75%的女性，会导致盆腔不适、大量出血和生育问题。标准治疗方法存在如肝损伤和骨密度降低等风险。传统医学（TM）提供了替代方法。我们发现，来自PubMed、谷歌学术、科学Direct的数据以及使用Dimension AI进行的文献计量分析都支持传统医学的疗效。在本综述中，我们研究了阿育吠陀医学、尤纳尼医学、悉达医学、顺势疗法、瑜伽、拔罐疗法和针灸等领域的21个案例研究，结果显示在缩小肌瘤大小和缓解症状方面取得了令人鼓舞的成果，且均无明显副作用。传统医学干预具有巨大潜力，但缺乏确凿证据。这凸显了传统医学在管理子宫肌瘤方面的潜力以及进一步开展研究和临床试验以进行验证的必要性。将传统医学纳入医疗保健可能会改善患者预后并降低成本。
